angiotensin ii, des-phe(8)- has been researched along with tyrosine in 2 studies
| Studies (angiotensin ii, des-phe(8)-) | Trials (angiotensin ii, des-phe(8)-) | Recent Studies (post-2010) (angiotensin ii, des-phe(8)-) | Studies (tyrosine) | Trials (tyrosine) | Recent Studies (post-2010) (tyrosine) |
|---|---|---|---|---|---|
| 1,533 | 21 | 995 | 44,273 | 846 | 8,225 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dominici, FP; Giani, JF; Gironacci, MM; Muñoz, MC; Turyn, D | 1 |
| Papinska, AM; Rodgers, KE | 1 |
2 other study(ies) available for angiotensin ii, des-phe(8)- and tyrosine
| Article | Year |
|---|---|
Angiotensin-(1-7) has a dual role on growth-promoting signalling pathways in rat heart in vivo by stimulating STAT3 and STAT5a/b phosphorylation and inhibiting angiotensin II-stimulated ERK1/2 and Rho kinase activity.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blotting, Western; Dose-Response Relationship, Drug; Growth; Heart; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Peptide Fragments; Phosphorylation; Rats; Receptor, Angiotensin, Type 1; rho-Associated Kinases; Signal Transduction; STAT3 Transcription Factor; STAT5 Transcription Factor; Tyrosine | 2008 |
Long-Term Administration of Angiotensin (1-7) to
Topics: Angiotensin I; Animals; Diabetes Mellitus, Experimental; Gene Expression Regulation, Enzymologic; Kidney; Kidney Glomerulus; Male; Mice, Inbred C57BL; NADPH Oxidases; Nitric Oxide Synthase Type III; Oxidative Stress; Peptide Fragments; Phosphorylation; Shear Strength; Tyrosine | 2018 |